ARCHIVES

Kadcyla Extends Median PFS In Open-Label Phase III Trial

This article is from The Cancer Letter archive.

Vol. 36 No. 10 | October 25, 2013

Download PDF Visit The Full Archive

Related Articles

Oral Combination Provides Alternative To IV Chemo For Multiple Myeloma

November 29, 2002

News Analysis: The Political Economy of Importation to Alleviate Cancer Drug Shortages

March 2, 2012

Spending Bill Expected At White House Any Day Now; NIH Awaits 15% Increase.

October 27, 2000

NTP Board Okays Modification Of Bioassay Protocols

April 9, 1982

Health Reform Bill Contains Unpleasant Surprises For Drug Manufacturers

November 5, 1993

House-Senate Conferees agree On NCI Total for FY’89, Then Cut It $19 Million

August 26, 1988